Highlights•Chemotherapy-induced neutropenia can lead to poor clinical outcomes.•CIN can
lead to infections, hospitalizations, mortality, and lower chemotherapy dose intensity.•G-CSF …

Abstract We compared the Multinational Association of Supportive Care in Cancer (MASCC)
and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for identifying serious …

Febrile neutropenia (FN) is an oncological emergency and serious complication often
resulting from chemotherapy. In patients with a weak or completely suppressed immune …

Febrile neutropenia (FN) is a common dose-limiting toxicity of chemotherapy, with a
profound impact on the evolution of patients with cancer, due to the potential development of …

Study objective Although validated risk-stratification tools have been used to send low-risk
febrile neutropenic patients home from clinic and inpatient settings, there is a dearth of …

Chemotherapy-induced neutropenia (CIN) is the major dose‑limiting toxicity of systemic
chemotherapy and it is associated with significant morbidity, mortality and treatment cost …

Objective: To analyze the interventions performed by health professionals with a view to
managing chemotherapy-induced febrile neutropenia. Method: Integrative literature review …

Febrile neutropenia (FN) is a common but serious complication encountered in patients with
cancer and is associated with significant morbidity and mortality. In this prospective study, 63 …

PURPOSE: Temporary COVID-19 guideline recommendations have recently been issued to
expand the use of colony-stimulating factors in patients with cancer with intermediate to high …

Lung cancer, compared with other solid tumors, is associated with high mortality rates from
febrile neutropenia. The risk factors associated with in-hospital mortality were identified and …